Literature DB >> 36267336

New mycosis fungoides-like lymphomatoid reaction following COVID-19 vaccination: A case report.

Heidi Oi-Yee Li1,2, Jennifer Lipson1.   

Abstract

Numerous cutaneous side effects arising from COVID-19 vaccination have been reported. Mycosis fungoides (MF) is a rare indolent form of cutaneous t-cell lymphoma. While the pathogenesis of MF is not well understood, it is thought to involve immune dysregulation. There have been reports of COVID-19 vaccination induced flares and recurrences of cutaneous lymphomas and lymphomatoid reactions. We present the first reported case of COVID-19 vaccine induced MF-like lymphomatoid reaction.
© The Author(s) 2022.

Entities:  

Keywords:  COVID-19 vaccination; Mycosis Fungoides; case report

Year:  2022        PMID： 36267336      PMCID： PMC9577074          DOI： 10.1177/2050313X221131859

Source DB:  PubMed          Journal:  SAGE Open Med Case Rep        ISSN： 2050-313X


  10 in total

Review 1.  Cutaneous pseudolymphoma-A review on the spectrum and a proposal for a new classification.

Authors:  Christina Mitteldorf; Werner Kempf
Journal:  J Cutan Pathol       Date:  2019-07-31       Impact factor: 1.587

2.  Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.

Authors:  Caitlin M Brumfiel; Meera H Patel; David J DiCaudo; Allison C Rosenthal; Mark R Pittelkow; Aaron R Mangold
Journal:  Leuk Lymphoma       Date:  2021-05-11

Review 3.  Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.

Authors:  T Krejsgaard; N Odum; C Geisler; M A Wasik; A Woetmann
Journal:  Leukemia       Date:  2011-09-09       Impact factor: 11.528

4.  Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.

Authors:  Mark M Painter; Divij Mathew; Rishi R Goel; Sokratis A Apostolidis; Ajinkya Pattekar; Oliva Kuthuru; Amy E Baxter; Ramin S Herati; Derek A Oldridge; Sigrid Gouma; Philip Hicks; Sarah Dysinger; Kendall A Lundgreen; Leticia Kuri-Cervantes; Sharon Adamski; Amanda Hicks; Scott Korte; Josephine R Giles; Madison E Weirick; Christopher M McAllister; Jeanette Dougherty; Sherea Long; Kurt D'Andrea; Jacob T Hamilton; Michael R Betts; Paul Bates; Scott E Hensley; Alba Grifoni; Daniela Weiskopf; Alessandro Sette; Allison R Greenplate; E John Wherry
Journal:  Immunity       Date:  2021-08-13       Impact factor: 43.474

5.  Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination.

Authors:  E Panou; V Nikolaou; L Marinos; S Kallambou; P Sidiropoulou; M Gerochristou; A Stratigos
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-31       Impact factor: 9.228

6.  Environmental and Other Extrinsic Risk Factors Contributing to the Pathogenesis of Cutaneous T Cell Lymphoma (CTCL).

Authors:  Feras M Ghazawi; Nebras Alghazawi; Michelle Le; Elena Netchiporouk; Steven J Glassman; Denis Sasseville; Ivan V Litvinov
Journal:  Front Oncol       Date:  2019-04-18       Impact factor: 6.244

7.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

Authors:  Devon E McMahon; Erin Amerson; Misha Rosenbach; Jules B Lipoff; Danna Moustafa; Anisha Tyagi; Seemal R Desai; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Kimberly G Blumenthal; Lindy P Fox; Esther E Freeman
Journal:  J Am Acad Dermatol       Date:  2021-04-07       Impact factor: 11.527

8.  Rare lymphomatoid reactions following SARS-CoV-2 vaccination.

Authors:  Tessa LeWitt; Christopher Chung; Janelle Manton; Artem Sergeyenko; Timothy Tan; Alicia Sigal; Xiaolong Alan Zhou; Joan Guitart
Journal:  JAAD Case Rep       Date:  2021-12-14

9.  The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?

Authors:  G Damiani; A Pacifico; F Pelloni; M Iorizzo
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-13       Impact factor: 6.166
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.